Age-Related Macular Degeneration (AMD) – Payer Implications Fact SheetJuly 3, 2024 Don’t miss this new CE activity for pharmacists, nurses, and physicians. Related ArticlesKey Insights Infographic: Assessing Recent Advances for Enhanced Management of Retinal DiseasesFacilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Managed Care Pathway for Better Management of Retinal Vein Occlusion (RVO)Diabetic Retinopathy/Diabetic Macular Edema (DR/DME) - Payer Implications Fact SheetFacilitating Optimal Outcomes for the Management of Retinal Diseases:Health Plan Best Practice RecommendationsManaged Care Pathway for Better Management of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations: Managed Care Pathway for Better Management of Age-related Macular Degeneration (AMD)